Wikidata

(Q114737579)

English

Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma

scientific article published on 06 March 2020

In more languages
default for all languages
No label defined

No description defined

Statements

title
Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma (English)
1 reference
stated in
Crossref
DOI
10.1200/JCO.2007.25.18_SUPPL.3000
reference URL
https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2007.25.18_SUPPL.3000
retrieved
18 October 2022
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q114737579&oldid=1785558796"